Literature DB >> 6224294

Down's syndrome in adults: brain metabolism.

M Schwartz, R Duara, J Haxby, C Grady, B J White, R M Kessler, A D Kay, N R Cutler, S I Rapoport.   

Abstract

The cerebral metabolic rate for glucose, as measured with positron emission tomography and fluorine-18-labeled 2-deoxy-D-glucose, was significantly higher in four healthy young subjects with trisomy 21 syndrome (Down's syndrome) than the mean rate in healthy young controls. The rate of cerebral glucose utilization in the frontal lobe of a 51-year-old subject with Down's syndrome was significantly lower than the rate in the young subjects with this syndrome, but approximated the rate in middle-aged controls. Thus glucose utilization by the brain appears to be excessive in young adults with Down's syndrome but may decline with age in some brain regions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224294     DOI: 10.1126/science.6224294

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.

Authors:  M B Schapiro; J V Haxby; C L Grady; R Duara; N L Schlageter; B White; A Moore; M Sundaram; S M Larson; S I Rapoport
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

Review 2.  Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.

Authors:  Alessandra C Martini; Thomas J Gross; Elizabeth Head; Mark Mapstone
Journal:  Neuron       Date:  2022-04-25       Impact factor: 18.688

3.  Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation.

Authors:  W Chen; E J Novotny; X H Zhu; D L Rothman; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 4.  Molecular genetics of human chromosome 21.

Authors:  P C Watkins; R E Tanzi; S V Cheng; J F Gusella
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

5.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987

6.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

Review 7.  Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.

Authors:  Elizabeth Head; David K Powell; Frederick A Schmitt
Journal:  Front Aging Neurosci       Date:  2018-06-21       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.